Clinical Advisory Board

Richard T. Kloos, MD

Richard T. Kloos, MD is a professor in the divisions of Endocrinology and Metabolism, and Nuclear Medicine at The Ohio State University (OSU), the Arthur G. James Cancer Hospital and the Richard J. Solove Research Institute, and the Comprehensive Cancer Center in Columbus, Ohio. Dr. Kloos is board certified in both nuclear medicine and internal medicine, with subspecialty certification in endocrinology, diabetes, and metabolism. He is co-director of The OSU Thyroid Cancer Unit and is a member of the National Comprehensive Cancer Network (NCCN) Guidelines Committee for thyroid carcinoma since 1998. He is a member and past secretary/chief operating officer for the American Thyroid Association (ATA) and served on their Guidelines Task Forces for thyroid nodules and differentiated thyroid cancer, published in 2006 and 2009. He is chairman of the ATA Guidelines Task Force for medullary thyroid cancer since 2006.

Paul W. Ladenson, MD

Paul W. Ladenson is the John Eager Howard Professor of Endocrinology and Metabolism and Director of the Division of Endocrinology and Metabolism at the Johns Hopkins Medical Institutions. Dr. Ladenson was educated at Dartmouth College, Oxford University, and Harvard Medical School before training in Internal Medicine and in Endocrinology and Metabolism at the Massachusetts General Hospital. Dr. Ladenson has served as editor-in-chief of the Journal of Clinical Endocrinology and Metabolism and president of the American Thyroid Association. His research interests focus on thyroid cancer, thyroid hormone analogues, and health economic aspects of thyroid disease management.  He is a Distinguished University Professor at Johns Hopkins and a past recipient of the American Thyroid Association's Paul Starr Award for career achievements in thyroid research.

Steven I. Sherman, MD, FACE

Steven I. Sherman is chair and professor at the Department of Endocrine Neoplasia and Hormonal Disorders at the University of Texas M.D. Anderson Cancer Center in Houston, Texas. Dr. Sherman also serves on the Medical Advisory Council of ThyCa: Thyroid Cancer Survivors’ Association and the thyroid cancer guidelines panels of both the National Comprehensive Cancer Network Guidelines Program and the American Thyroid Association. He currently is Treasurer of the International Thyroid Oncology Group. His research interests include novel therapies and approaches toward treatment in thyroid carcinoma. Dr. Sherman has published more than 90 articles and editorials in peer-reviewed journals. He graduated from Johns Hopkins School of Medicine and is board-certified in internal medicine and endocrinology, diabetes and metabolism.

R. Michael Tuttle, MD

R. Michael Tuttle is currently an endocrinologist at the Memorial Sloan-Kettering Cancer Center in New York, New York and Professor at the Cornell School of Medicine. He is a board of directors member of the American Thyroid Association and serves on the Medical Advisory Council of ThyCa (Thyroid Cancer Survivors’ Association). Dr. Tuttle’s research is focused on investigational therapies for thyroid cancer. He was educated at the University of Louisville School of Medicine and was a resident at the Dwight David Eisenhower Army Medical Center.